Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rotmensch

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
American Journal of Obstetrics and Gynecology|February 15, 1981
Significance of the sinusoidal fetal heart rate patternT R Johnson, A A Compton, J Rotmensch, et al.
American Journal of Obstetrics and Gynecology|September 15, 1981
Urinary estrogens in postterm pregnancyV A Khouzami, J W Johnson, E Hernandez, et al.
Gynecologic Oncology|November 25, 1998
Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapyA J Mundt, P P Connell, T Campbell, et al.
Gynecologic Oncology|September 5, 2001
Phase I trial of concomitant vinorelbine, paclitaxel, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignanciesA J Mundt, J Rotmensch, S E Waggoner, et al.
Obstetrics and Gynecology|December 1, 1981
Primary, papillary peritoneal neoplasiaR Genadry, S Poliakoff, J Rotmensch, et al.
Gynecologic Oncology|September 1, 1990
Estimates of dose to intraperitoneal micrometastases from alpha and beta emitters in radioimmunotherapyJ Rotmensch, J Roeske, G Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|December 21, 2000
Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignanciesJ C Roeske, A Lujan, J Rotmensch, et al.
Mutation Research|May 1, 1991
The effects of radon daughter alpha-particle irradiation in K1 and xrs-5 CHO cell linesJ D Shadley, J L Whitlock, J Rotmensch, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2001
Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapyA J Mundt, R McBride, J Rotmensch, et al.
Gynecologic Oncology|December 6, 2001
Outcome and management of pathological stage I endometrial carcinoma patients with involvement of the lower uterine segmentC Phelan, A G Montag, J Rotmensch, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
American Journal of Obstetrics and Gynecology|February 15, 1981
Significance of the sinusoidal fetal heart rate patternT R Johnson, A A Compton, J Rotmensch, et al.
American Journal of Obstetrics and Gynecology|September 15, 1981
Urinary estrogens in postterm pregnancyV A Khouzami, J W Johnson, E Hernandez, et al.
Gynecologic Oncology|November 25, 1998
Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapyA J Mundt, P P Connell, T Campbell, et al.
Gynecologic Oncology|September 5, 2001
Phase I trial of concomitant vinorelbine, paclitaxel, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignanciesA J Mundt, J Rotmensch, S E Waggoner, et al.
Obstetrics and Gynecology|December 1, 1981
Primary, papillary peritoneal neoplasiaR Genadry, S Poliakoff, J Rotmensch, et al.
Gynecologic Oncology|September 1, 1990
Estimates of dose to intraperitoneal micrometastases from alpha and beta emitters in radioimmunotherapyJ Rotmensch, J Roeske, G Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|December 21, 2000
Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignanciesJ C Roeske, A Lujan, J Rotmensch, et al.
Mutation Research|May 1, 1991
The effects of radon daughter alpha-particle irradiation in K1 and xrs-5 CHO cell linesJ D Shadley, J L Whitlock, J Rotmensch, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2001
Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapyA J Mundt, R McBride, J Rotmensch, et al.
Gynecologic Oncology|December 6, 2001
Outcome and management of pathological stage I endometrial carcinoma patients with involvement of the lower uterine segmentC Phelan, A G Montag, J Rotmensch, et al.
Pageof 8